Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04542993 |
|---|---|
| Brief Title: | Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy (Reszinate) |
| First Submitted : | September 8, 2020 |
| First Submitted that Met QC Criteria : | September 8, 2020 |
| First Posted : | September 9, 2020 |
| Last Update Submitted that Met QC Criteria : | October 14, 2020 |
| Last Update Posted : | October 19, 2020 |